About this episode

Dan Schmitt discusses innovative drug developments for hard-to-treat cancers ahead of the 2026 ASCO Annual Meeting.

On this episode of BioTech Nation, Dan Schmitt of Actuate Therapeutics talks about a new kind of drug showing positive early results in hard-to-treat cancer - including adult pancreatic cancer, and two pediatric cancers. So, what’s next? Global collaborations, international trials, and efforts into different types of cancer…and they’re showing no sign of slowing down.

More episodes of BioTech Nation ... with Dr. Moira Gunn

• A Not-in-the-Textbooks Discovery for Glioblastoma, Jay Hartenbach & Dr. Will Decker, Diakonos Oncology · July 21, 2026 · 24 min
• Two Drug Approvals in Two Years...Michael Metzger, CEO, Syndax Pharmaceuticals · May 28, 2026 · 13 min
• A Different Way to Treat Parkinson's...Dr. Jonas Hannestad & Dr. Joanne Taylor, Gain Therapeutics · May 19, 2026 · 13 min
• Looking Back: A 2007 Interview with Dr. J. Craig Venter · May 12, 2026 · 17 min

Explore listener stats, chart rankings, contacts and more on the BioTech Nation ... with Dr. Moira Gunn podcast page.